2019
DOI: 10.1007/s12029-019-00296-9
|View full text |Cite
|
Sign up to set email alerts
|

The Anticancer Efficacy of Platinum Azidothymidin on Hepatocellular Carcinoma Via Affecting the Telomerase and the BcL-2 Genes Expression

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 16 publications
0
1
0
Order By: Relevance
“…Furthermore, it is interesting to note that some drugs, such as Azidothymidin [51] and PI3K δ inhibitors [52] , despite not appearing to have a direct effect on TERT, have shown promising results in murine models, also presenting a reduction of TERT activity itself. It is therefore important to understand the involvement of TERT in the carcinogenesis pathway of HCC, given the pivotal role that it seems to have, with a subsequent therapeutic potential.…”
Section: Treatment Perspectivesmentioning
confidence: 99%
“…Furthermore, it is interesting to note that some drugs, such as Azidothymidin [51] and PI3K δ inhibitors [52] , despite not appearing to have a direct effect on TERT, have shown promising results in murine models, also presenting a reduction of TERT activity itself. It is therefore important to understand the involvement of TERT in the carcinogenesis pathway of HCC, given the pivotal role that it seems to have, with a subsequent therapeutic potential.…”
Section: Treatment Perspectivesmentioning
confidence: 99%